| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |